• LAST PRICE
    1.9000
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-2.0619%)
  • Bid / Lots
    1.8500/ 1
  • Ask / Lots
    1.9700/ 10
  • Open / Previous Close
    1.9100 / 1.9400
  • Day Range
    Low 1.8600
    High 1.9450
  • 52 Week Range
    Low 1.2400
    High 4.4300
  • Volume
    388,174
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.94
TimeVolumeFBIO
09:32 ET185541.945
09:34 ET13501.94
09:36 ET28201.945
09:38 ET27261.92
09:41 ET135231.89
09:43 ET40501.9
09:48 ET10041.8913
09:50 ET19011.89
09:52 ET117481.87
09:54 ET7001.8701
09:56 ET23521.87
09:57 ET3001.865
09:59 ET158141.87
10:01 ET5001.89
10:03 ET14061.89
10:06 ET2001.89
10:08 ET11601.88
10:10 ET22001.88
10:12 ET1001.885
10:14 ET129271.885
10:17 ET16001.8897
10:19 ET5501.9
10:21 ET62961.9007
10:24 ET23201.91
10:28 ET23071.9
10:30 ET21001.9006
10:32 ET114251.89
10:33 ET75541.9
10:35 ET5361.9095
10:37 ET1871.9044
10:39 ET8001.8997
10:42 ET75001.89
10:44 ET1001.899
10:46 ET5001.895
10:50 ET52321.885
10:53 ET2651.88
10:55 ET34001.89
10:57 ET1001.89
11:00 ET37971.9017
11:02 ET10001.8987
11:04 ET17921.88
11:06 ET7001.89
11:09 ET7001.89
11:15 ET7001.8884
11:24 ET3361.8896
11:26 ET2731.8809
11:31 ET15001.885
11:33 ET10001.8807
11:42 ET10001.8808
11:44 ET1001.885
11:45 ET26521.885
11:47 ET15001.8899
11:49 ET5201.885
11:54 ET4001.8899
11:56 ET50561.871
11:58 ET20161.86
12:02 ET2411.878
12:03 ET59701.89
12:05 ET14001.8801
12:12 ET30061.89
12:18 ET1001.88
12:20 ET10581.88
12:21 ET1001.89
12:25 ET30001.8899
12:34 ET1001.885
12:38 ET5001.88
12:39 ET1001.8793
12:43 ET7401.8707
12:45 ET5001.88
12:48 ET39051.8799
12:50 ET5871.875
12:52 ET1001.875
12:54 ET60001.8753
12:56 ET1001.88
12:57 ET5001.8799
12:59 ET2011.875
01:03 ET17001.875
01:08 ET41001.8799
01:10 ET2581.885
01:12 ET14501.88
01:14 ET3001.8701
01:19 ET9001.87
01:21 ET1001.88
01:30 ET1131.88
01:33 ET39001.87
01:35 ET35031.87
01:53 ET31001.87
02:02 ET2221.865
02:04 ET28091.87
02:06 ET12001.8699
02:08 ET38751.87
02:09 ET6001.875
02:20 ET25001.8797
02:24 ET10871.89
02:27 ET4901.8893
02:33 ET1251.8801
02:36 ET1001.88
02:38 ET4631.876
02:40 ET19901.88
02:42 ET6871.8701
02:44 ET3001.88
02:45 ET4001.87
02:47 ET3001.875
02:51 ET12001.8798
02:54 ET8681.88
03:00 ET14001.885
03:03 ET37301.885
03:05 ET11001.8864
03:07 ET18801.89
03:12 ET1001.895
03:14 ET13001.895
03:18 ET9141.8941
03:20 ET6501.895
03:21 ET70021.895
03:23 ET2001.895
03:27 ET1001.9
03:30 ET101201.8995
03:32 ET11041.895
03:34 ET109571.895
03:39 ET76461.895
03:41 ET13451.9
03:43 ET10001.895
03:48 ET8001.8988
03:50 ET20541.9
03:52 ET176331.9
03:54 ET176721.9
03:56 ET41801.925
03:57 ET12001.915
03:59 ET231941.9
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFBIO
Fortress Biotech Inc
53.5M
-0.5x
---
United StatesCBIH
Cannabis Bioscience International Holdings Inc
7.4M
0.0x
---
United StatesAYTU
Aytu Biopharma Inc
12.2M
-0.7x
---
United StatesWUHN
Wuhan General Group (China) Inc
5.5K
0.0x
---
United StatesCTMX
CytomX Therapeutics Inc
77.5M
7.3x
---
United StatesMDXH
MDxHealth SA
96.5M
-1.3x
---
As of 2024-10-31

Company Information

Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases and gene therapy. Its dermatology products include Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Exelderm and Luxamend. Its late stage product candidates include Cosibelimab (anti-PD-L1 antibody), DFD-29 (modified release oral minocycline for the treatment of rosacea), CUTX-101 (copper histidinate injection for Menkes disease), IV Tramadol, Olafertinib (also known as CK-101, EGFR inhibitor for EGFR mutation-positive NSCLC), CAEL-101 (monoclonal antibody for AL amyloidosis) and Triplex (cytomegalovirus (CMV) vaccine).

Contact Information

Headquarters
1111 KANE CONCOURSE, SUITE 301BAY HARBOR ISLANDS, FL, United States 33154
Phone
781-652-4500
Fax
781-652-4545

Executives

Executive Chairman of the Board, President, Chief Executive Officer
Lindsay Rosenwald
Chief Financial Officer and Head of Corporate Development
David Jin
Executive Vice Chairman - Strategic Development, Director
Michael Weiss
Senior Vice President - Biologics Operations
George Avgerinos
Independent Director
Jimmie Harvey

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$53.5M
Revenue (TTM)
$82.6M
Shares Outstanding
27.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.79
EPS
$-3.71
Book Value
$1.49
P/E Ratio
-0.5x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
---
Operating Margin
-118.28%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.